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1. Introduction
The postreplicative methylation of DNA at the C5 position of cytosines is 
found in a broad spectrum of organisms ranging from prokaryotes to human 
(1). In prokaryotes the major role of cytosine C5 methylation (like adenine N6 
and cytosine N4 methylation) is to protect the genome against DNA degrading 
nucleases (restriction/modiﬁcation), whereas in many eukaryotes cytosine 
C5 methylation (found within CpG dinucleotides) plays a pivotal role in the 
control of gene expression, inactivation of repetitive sequences, stability of 
chromosomes, and in cell transformation leading to development of cancer. The 
growing evidence that the cytosine methylation is also crucial in embryonic 
development of mammals regulating genomic imprinting, X inactivation and 
cell differentiation (2) has caused a demand for effective methods that would 
detect this modiﬁcation with high sensitivity and reliability.
Original methods to detect sequence speciﬁc genomic methylation were 
based on the digestion of DNA by methylation-sensitive restriction enzymes 
and subsequent Southern-blot hybridization (3). Despite rather high amounts 
of DNA needed for such experiments and the possibility to investigate just 
the limited numbers of CpGs situated within suitable restriction sites, the 
method is still useful as the first indication of methylation in a specific 
region. To improve the sensitivity, the method was combined with polymerase 
chain reaction (PCR) ampliﬁcation (4) and subsequent quantiﬁcation of PCR 
products (5,6). Although the use of PCR decreased the amount of template 
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DNA necessary for the analysis, the whole procedure is highly demanding in 
terms of strictly standardized conditions of DNA preparation and PCR, since 
quantiﬁcation is only possible within the exponential phase of ampliﬁcation.
Additionally, incomplete digestion of chromosomal DNA might be a frequent 
source of artefacts. Another disadvantage of such methods is that they provide 
data only about the average level of methylation; it is neither possible to 
discriminate between mosaic or even methylation patterns nor to address 
hemi-methylation, which remains in general undetected.
The ﬁrst information about the methylation of cytosine residues irrespective 
of their sequence context was obtained using a genomic sequencing protocol 
(7). This method identiﬁes a position of 5-methylcytosine (5-MeC) in the 
genomic DNA as a site that is not cleaved by any of the Maxam and Gilbert 
sequencing reactions (8) and thus appears as a gap in a sequencing ladder. 
Although a detailed distribution of methylation in a given sequence can be 
analyzed by this method, it still requires relatively large amounts of genomic 
DNA and a certain level of experience in interpreting the sequencing results as 
bands of varying intensity and shadow bands may occur. An elegant combina-
tion of the chemical cleavage method with ligation mediated PCR (9) increases
the sensitivity, but this modiﬁcation makes the whole procedure rather laborious 
and technically challenging.
With a bisulphite genomic-sequencing method (10,11), a qualitatively 
and quantitatively new approach to methylation analysis has appeared. The 
bisulphite reaction leads to the conversion of cytosines into uracil residues, 
which are recognized as thymines in subsequent PCR amplification and 
sequencing, whereas the modiﬁed cytosines do not react and are therefore 
detected as cytosines. Thus the method allows direct and positive determination 
of methylation sites in the genomic DNA, as only methylated cytosines are 
detected as cytosines. Products of PCR-ampliﬁed bisulphite-treated DNA can 
be used directly for sequencing (detection of average methylation status) or 
cloned and sequenced individually, when the information about the methylation 
pattern of single molecules is desired. Not only the methylation status of each 
single molecule but also the pattern of each DNA strand can be investigated, 
as the strands are no longer complementary following the bisulphite treatment 
and are ampliﬁed and sequenced separately.
Several modiﬁcations of the original bisulphite sequencing protocol improv-
ing the sensitivity and quality of the results have been published (11–15).
In some cases a direct sequence analysis of the PCR products obtained may 
be desirable to estimate the average methylation at speciﬁc sites. For such 
direct quantitation Gonzalgo and Jones (16), proposed an elegant and simple 
procedure (Ms-SNuPE). A more sophisticated protocol for direct quantitation 
of sequencing results is described by Paul et al. (17).
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The attributes of high sensitivity, the ability to detect single-molecule methyla-
tion patterns as well as the possibility of addressing nonsymmetrical methylation 
make bisulphite-based genomic sequencing the method of choice for a variety 
of applications. The following protocol used routinely in our laboratory is based 
on the previously published procedure (14); several modiﬁcations are included 
leading to easier handling and less time-consuming experimental procedure.
2. Materials
2.1. Embedding of Material into Agarose and Bisulphite Reaction
1. Trypsin: 0.25% [w/v] in PBS (Biochrom).
2. Mineral oil: heavy white mineral oil (Sigma).
3. LMP agarose (SeaPlaque Agarose, FMC).
4. Proteinase K (Boehringer Mannheim).
5. Hydroquinone (Sigma).
6. Phenylmethylsulphonyl ﬂuoride (PMSF) (Sigma).
7. Sodium disulphite: (Sodium metabisulphite) (Merck).
Note: Batches of commercially available sodium bisulphite are mixtures of 
sodium bisulphite and sodium metabisulphite. The ratio between the substances 
may vary among different batches. We recommend working with pure sodium 
metabisulphite, which facilitates accurate preparation of solutions with the 
desired molarity.
Common laboratory solutions and buffers like sodium dodecyl sulfate (SDS), 
ethylenediaminetetraacetic acid (EDTA), phosphate-buffered saline (PBS), 
Tris-HCl, pH8.0, NaOH, TE were prepared according to ref. 17a.
2.2. PCR, Puriﬁ cation, and Cloning of PCR Product
1. Taq polymerase (Boehringer Mannheim).
2. Geneclean II (Bio 101), or equivalent method, for puriﬁcation of PCR fragments 
from agarose gels.
3. TA cloning kit (Invitrogene) with INVα F` ultra-competent Escherichia coli cells.
For some bisulphite–PCR fragments we observed a clonal selection against 
fully converted templates. In those cases we were able to overcome the problem 
using a different cloning vector system (pGEM-T, Promega) in combination 
with competent Sure E.coli cells.
3. Method
3.1. Chemistry of the Bisulphite Reaction
The reaction of cytosine residues with sodium bisulphite leading to selec-
tive conversion to uracils was first published in early 1970s (18,19) for 
conformational studies of single- and double-stranded regions in DNA and 
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RNA (20–22). The reaction generally consists of three major steps (Fig. 1):
1) sulphonation, 2) deamination, and 3) desulphonation (18).
1. Reversible sulphonation of cytosine residues to cytosine-6-sulphonate. The 
sulphonation is favored at low pH and low temperature; at 0°C the equilibrium 
state is reached within 20 min.
2. Irreversible hydrolytic deamination of cytosin-6-sulphonate to uracil-6-sulphonate. 
This reaction is favored at higher concentrations of sodium bisulphite and at 
higher temperatures; the pH optimum is between pH 5.0 and 6.0.
3. Reversible desulphonation of uracil-6-sulphonate to uracil. The elimination 
reaction is favored at high pH.
Only cytosines in single-stranded DNA (or its components) can be efﬁ -
ciently modiﬁed by sodium bisulphite; cytosines in nondenatured, double-
stranded DNA are almost refractory to react. Furthermore, under the conditions 
described, the reaction is highly selective for nonmethylated cytosine residues, 
which are quantitatively modiﬁed (converted to uracils), whereas only 2–3% of 
5-methylcytosine residues do react and are converted to thymines (23).
3.2. Principles of the Method
The following protocol is a modiﬁed version of the original bisulphite-based 
methylation-analysis technique described by Frommer et al. (10). As a main 
difference we routinely embed the material under investigation (i.e., either 
isolated DNA or intact cells) into low melting point (LMP) agarose. All the 
following modiﬁcation steps are performed in the agarose in which the DNA is 
physically captured. The described modiﬁcation greatly facilitates the handling 
of the probes and reduces the loss of DNA in the procedure, thus allowing to 
work with minute DNA or cell/tissue quantities. The embedding also reduces 
the reannealing of denatured DNA strands therefore ensuring highest quality 
and reproducibility in the bisulphite reaction. The principles described in this 
Fig. 1. Chemistry of the reaction steps: I) sulphonation at the position C6 of cytosine, 
II) irreversible hydrolytic deamination at the position C4 generating 6-sulphonate-
uracil, and III) subsequent desulphonation under alkaline conditions. Note that 
methylation at the position C5 impedes sulphonation at the C6 position (step 1).
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paragraph refer to a procedure when working with intact cells (see Subhead-
ings 3.3. and 3.4.). A modiﬁed version of this protocol (see Subheading 3.4.)
should be applied when using puriﬁed DNA.
When intact cells are used as a starting material they are embedded into
an agarose, lysed, and treated with Proteinase K to make the genomic DNA 
accessible for subsequent bisulphite treatment. We recommend including an
endonuclease restriction step (with a methylation-insensitive enzyme) to 
obtain smaller DNA fragments (of about 3–6 kb), which enhances the spatial 
separation of complementary DNA strands after the following denaturation. 
Agarose-embedded (and -digested) DNA is denatured by alkaline treatment and 
boiling. Nonmethylated cytosine residues in single strands are subsequently 
modiﬁed in the presence of 2.5 M sodium bisulphite (see experimental pro-
cedures concerning preparation of solutions), converted to uracil residues 
by following alkaline treatment, washed extensively and stored in minimal 
volumes of TE (Fig. 1). The sequence of interest is finally amplified by 
(nested) PCR. Due to the bisulphite treatment, DNA strands are no longer 
complementary, and therefore are ampliﬁed and analyzed separately (Fig. 2).
The PCR products can be used directly for sequencing, which allows the 
quantitation of average values of cytosine methylation at individual positions. 
Alternatively, the PCR product may be cloned and individual clones sequenced, 
the latter revealing information about individual chromosomes.
3.3. Preparation of Cells for Bisulphite Treatment
The following procedure should be used when working with limited amount 
of tissue (containing less than 1 ng of DNA in total) or only a few cells, in which 
cases the DNA isolation is difﬁcult. When larger quantities of cellular material 
are available like biopsies, parafﬁn-embedded tissues, sperm samples, and so 
on; we recommend ﬁrst isolating DNA and then proceeding with procedures 
described in Subheading 3.4.
1. When starting with tissue samples, this material should be trypsinized to obtain 
a single-cell suspension. In cases of individually collected cells (e.g., oocytes, 
zygotes, etc.) proceed directly to step 2.
2. Wash and recover the cells in 1X PBS solution at a maximum density of
60 cells/μL. (In case of oocytes/zygotes, 30–50 cells should be used per agarose 
bead.)
3. Mix 3 μL of cell suspension with 6 μL of hot (80°C) 2% (w/v) LMP agarose 
(SeaPlaque Agarose, FMC) (prepared in 1X PBS).
4. Add 500 μL of heavy mineral oil, incubate in boiling water bath for 30 min, and 
transfer to ice (additional 30 min) to solidify the agarose/cell mixture.
5. Incubate the agarose bead in 500 μL of the lysis solution (10 mM Tris-HCl, 10 mM
EDTA, 1% SDS, 20 μg/mL proteinase K) under the mineral oil at 37°C overnight.
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6. Remove the lysis solution and the oil and inactivate proteinase K in 500 μL of 
TE, pH 7.0, containing 40 μg/mL PMSF 2 × 45 min at room temperature (RT). 
(This step is optional.)
7. Remove the solution and wash with 1 mL of 1X TE, pH 9.0, 2 × 15 min (i.e. 
2 washes, 15 min each).
8. Equilibrate against 100 μL of restriction buffer 2 × 15 min.
9. Remove the solution and add 100 μL of 1X restriction buffer containing
20 units of restriction endonuclease and incubate overnight. (Alternatively add 
50 units for 1 h digestion.)
10. Remove the restriction buffer and incubate with 500 μL of 0.4 M NaOH
2 × 15 min.
11. Wash with 1 mL of 0.1 M NaOH for 5 min.
Fig. 2. Schematic diagram of the bisulphite conversion of a DNA sequence; note that 
the upper and lower strands are no longer complementary after the bisulphite treatment 
(a, adenine; c, cytosine; mc, 5-methyl-cytosine; g, guanine; t, thymine; u, uracil).
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12. Remove all the solution and overlay with 500 μL of mineral oil.
13. Boil the beads in a water bath for 20–30 min to separate the individual DNA 
strands.
14. Chill on ice for 25 min to re-solidify the agarose bead.
15. Prepare the bisulphite/hydroquinone solution according to Subheading 3.4., 
step 6.
16. Add 500 μL of the (ice-cold) bisulphite/hydroquinone solution. The agarose 
bead should be in the (lower) aqueous phase.
17. Proceed according to Subheading 3.4., step 9.
3.4. Bisulphite Treatment of Isolated DNA
Bisulphite and hydroquinone solutions are light-sensitive, thus should be 
protected from light in all steps.
1. Digest genomic DNA with a suitable restriction enzyme (which does not cut 
within the region to be ampliﬁed) in a volume of 21 μL. In order to achieve 
a complete bisulphite conversion, we recommend using not more than 700 ng 
DNA for the restriction, so that the DNA content of each (later on) formed 
agarose-DNA bead does not exceed 100 ng, see step 8.
2. Boil for 5 min in a water bath.
3. Chill on ice and quickly spin down.
4. Add 4 μL of 2 M NaOH (ﬁnal concentration 0.3 M NaOH) and incubate 15 min
at 50°C.
5. Mix with 2 vol (50 μL) of melted (50–65°C) 2% (w/v) LMP agarose (SeaPlaque 
Agarose, FMC; prepared in water).
6. Prepare 2.5 M bisulphite solution, pH 5.0, as follows: dissolve 1.9 g of sodium 
bisulphite in a mix of 2.5 mL H2O and 750 μL of 2M NaOH (freshly prepared), 
dissolve 55 mg of hydroquinone in 500 μL of H2O at 50°C, and mix both 
solutions.
7. Pipet 1 mL of the bisulphite/hydroquinone solution into a 2-mL Eppendorf tube 
and overlay with 750 μL of heavy mineral oil (tubes should be kept for 30 min 
on ice before proceeding).
8. Pipet up to seven 10 μL-aliquotes of the DNA-agarose mixture into ice-cold 
mineral oil to form beads. (Each bead should contain up to 100 ng of DNA.) 
Make sure that all beads have entered the aqueous phase; beads can be pushed 
into the bisulphite solution using a pipet tip.
9. Leave on ice for 30 min.
10. Incubate at 50°C for 3.5 h.
11. Remove all solutions; wash with 1 mL of 1X TE, pH 8.0 for 4 × 15 min.
12. Add 500 μL of 0.2 M NaOH 2 × 15 min.
13. Remove NaOH solution and wash with 1 ml of 1X TE, pH 8.0, 3 × 10 min. 
Store in a small volume of TE, pH 8.0, at 4°C (beads are stable for at least 
several weeks).
14. Prior to ampliﬁcation wash the beads with H2O for 2 × 15 min.
150                                                                                    Hajkova et al.
3.5. General Recommendations
3.5.1. Primer Design
The guidelines for primer design for the ampliﬁcation of bisulphite-treated 
DNA presented here concern methylation patterns found in mammalian 
genomes (i.e., methylation mainly at CpG sites). Different requirements for 
primer design have to be considered when analyzing methylation patterns in 
organisms with a broader methylation spectrum (as CpNpG or nonsymmetrical 
cytosine methylation in plants or fungi, and so on; see Subheading 4.).
1. A bisulphite-treated DNA sequence should be generated using any word proces-
sor to replace all Cs for Ts except at CpG sites (e.g., for DNA methylation 
patterns in mammalian genomes). Any primer designing software that will help 
to avoid any hairpin structures and possible primer dimers can use this modiﬁed
sequence.
2. The length of the oligos should be at least 20 nucleotides and up to 25–30 
nucleotides.
3. The primers should be located in an originally cytosine-rich region so that they 
selectively amplify converted DNA.
4. Overlapping of the primers with CpG dinucleotides should be strictly avoided 
especially at the 3′ end of the oligos.
5. Extensive T and A stretches in both primers, which are typical for bisulphite-
treated DNA, should be avoided to minimize the formation of primer dimers.
3.5.2. Optimizing PCR Conditions
1. The PCR conditions for amplifying bisulphite-treated material should be care-
fully optimized. The bisulphite treatment reduces the sequence speciﬁcity (by 
changing all cytosines to uracils) and thus the selectivity for primer annealing.
2. It is recommended that the length of the product does not exceed 600–700 bp 
as longer fragments may be more difﬁcult to amplify from a bisulphite-treated 
DNA (due to depurination of DNA as a result of low pH during the bisulphite 
treatment).
3. A nested or at least a seminested approach for amplifying the target region is 
recommended to increase the sensitivity when working with limited numbers of 
cells and to ensure the speciﬁcity of the product.
4. To avoid any contamination with previous PCR products, the bisulphite treatment 
and handling of the DNA or cells should be carried in a separate room and 
using separate pipets.
5. A gradient PCR cycler is recommended to optimize the annealing temperature.
3.5.3. Cloning and Sequencing
1. To increase the efﬁciency of cloning, the speciﬁc PCR product should be puriﬁed
from any unspeciﬁc band(s) or primer dimers by agarose-gel elution.
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Table 1
Frequently Encountered Problems
Problem Recommended solution
1. The hydroquinone solution turns red. a. Protect the solution from light and do not heat
over 50°C to dissolve.
2. During incubation of the bisulphite- a. This will not affect the results: proceed 
hydroquinone solution on ice   normally.
crystals appear.
3. The beads disappear after entering  a. The mineral oil layer is not cold enough; the
the bisulphite solution.  tubes containing the mineral oil should be 
pre-incubated on ice for a longer period (at 
least 20 min) or alternatively they can be kept
at –20°C for 10 min, then the bisulphite
solution added after the formation of the beads.
b. Use only heavy mineral oil.
c. Increase the concentration of LMP agarose.
4. No PCR product is obtained. a. Inefﬁcient bisulphite conversion (see
   Subheading 3.4.).
b. The amount of template is not sufﬁcient.
c. The PCR product is too long for 
bisulphite-treated DNA; design primers
that amplify smaller fragments.
d. Use nested primers to increase the sensitivity 
and the yield of the ampliﬁcation.
e. Try different set of primers.
5. The PCR product is difﬁcult to clone. a. If a T/A cloning vectors are used: prior to
ligation, incubate the PCR product with 
additional amount of Taq polymerase and 
dATP (this would help to add a ﬂanking
A to the 3′ end of the product).
b. Try different cloning vectors and E. coli strains.
6. Unconverted sequences are  a. Primers are not selective enough for 
frequently observed.  converted DNA. The primers should be 
located in a C-rich region to increase  the
speciﬁcity of ampliﬁcation for converted 
sequences.
b. Incomplete bisulphite conversion may be 
caused by excess of DNA in reaction; the 
maximum recommended amount of DNA
per bead is 100 ng.
c. DNA was not properly denatured, make sure 
that denaturation steps and desulphonation 
steps are properly made using fresh NaOH
solution.
d. The bisulphite and hydroquinone solutions 
should be prepared fresh and stored no 
longer than 24 h before use.
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2. Cloning of the PCR product can be improved by additional incubation of the 
puriﬁed product in presence of dATP and Taq polymerase for 5 min at 95°C
followed by 60 min at 72°C. This will increase the percentage of DNA molecules 
with ﬂanking As at the 3′ end.
3. To verify the presence of the correct insert in plasmids, we routinely use a 
colony PCR protocol. Products of the correct size can be directly sequenced 
using internal primers.
4. According to our experience, blue/white screening of colonies is not always 
reliable (especially when short fragments are cloned). In such situation, we 
recommend analyzing all colonies, as the blue ones may contain an insert.
3.6. Drawbacks of the Bisulphite-Based Methylation Analysis
Although the bisulphite-based methylation analysis is a powerful tool 
to obtain detailed genomic-methylation data, it is connected with speciﬁc
experimental or technical problems, which are brieﬂy discussed here.
1. In order to perform a bisulphite-based methylation analysis, a detailed sequence 
information of the genomic region of interest is required.
2. The upper and lower strands of the bisulphite-treated DNA samples are analyzed 
separately. Therefore it is impossible (except for a single-cell approach) to obtain 
data about the original double-stranded DNA.
3. Ampliﬁcations (or cloning of PCR products) from the upper and lower strand 
may not work equally well in each case.
4. In case of analyzing methylation patterns of unknown distribution as, e.g., in plants 
and fungi, it may be difﬁcult to design primers for the PCR ampliﬁcation of the 
bisulphite-treated DNA. In this case primers can be designed that contain either C 
or T at the respective positions. However, the use of such primers with “wobble”
positions greatly reduces the sensitivity of the PCR reaction and may cause a bias 
in the ampliﬁcation towards speciﬁc (mostly not fully converted) products.
5. A systematic analysis (24) nicely demonstrated that the choice of primers might 
cause a bias in the PCR reaction, such that either the low or highly methylated 
template DNA is predominantly ampliﬁed. Another selection against a speciﬁc
subset of PCR products may occur during the cloning procedure. The problem 
of biased ampliﬁcation or cloning has to be tested individually and several 
control experiments should be carried out. First, different templates with a known 
content of methylated cytosine residues should be mixed in different ratios and 
the bisulphite treatment and ampliﬁcation steps should be carried out as usual. 
The distribution of nonconverted and converted cytosine residues in the analyzed 
products will then allow determination of whether and in which magnitude a bias 
occurs. Furthermore, independent experiments (including different techniques) 
should be used to analyze the methylation state of a given template, e.g., 
conventional Southern-blot hybridization or the Ms-SNuPE assay (16). Both 
experiments may be very helpful to obtain an independent impression of the real 
ratio of modiﬁed and unmodiﬁed cytosines within the sequence of interest.
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